Study Completed

Contraception, Male

Bayer Identifier:

90851

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study to assess Norethisterone Enanthate (NET-EN) plus Testosterone Undecanoate (TU) for male contraception

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Inclusion Criteria
Exclusion Criteria

Trial summary

Enrollment Goal

Trial Dates

July 2000 - December 2003

Phase

Phase 2

Could I Receive a placebo

N/A

Products

Norethisterone e./Testosterone u. (BAY86-5037)

Accepts Healthy Volunteer

N/A

Primary Outcome

Secondary Outcome

Trial design

Norethisterone enanthate (NET-EN) plus Testosterone undecanoate (TU) for male contraception - a prospective, randomized, 4-arm parallel-group, controlled single-blind study

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.